Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Nanopath has raised $100K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Nanopath's investors include Alumni Ventures, Norwest, National Science Foundation, National Institutes of Health, MassVentures.
Nanopath is headquartered in Cambridge, United States.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Nanopath is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanopath — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/nanopath. Accessed July 20, 2026.
VCBacked. (2025). Nanopath — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/nanopath
{{cite web |title=Nanopath — Funding & Investors |url=https://www.vcbacked.co/company/nanopath |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated